Nomura Holdings
ENZN

Nomura Holdings’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Nomura Holdings’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-30,492
Closed -$32K – 3253
2014
Q2 		$32K Buy
+30,492
New +$29.1K ﹤0.01% 2631

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Nomura Holdings's ENZN Position: Q3 2014 in Review

Nomura Holdings sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2014, closing a stake of 30,492 shares — an estimated $32K sold.

Nomura Holdings first reported a position in ENZN in Q2 2014 and held it in 1 quarter. The position peaked at $32K in Q2 2014. 65 funds tracked by Wall St. Rank hold ENZN as of Q3 2014.

  • Nomura Holdings reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Nomura Holdings sold 30,492 ENZON PHARMACEUTICALS INC shares in Q3 2014, an estimated $32K.
  • Nomura Holdings first reported a position in ENZON PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Nomura Holdings's ENZON PHARMACEUTICALS INC position peaked at $32K in Q2 2014.
  • 65 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2014.

Based on Nomura Holdings's 13F filing for Q3 2014, filed 14 Nov 2014.